Second primary cancers occurring after I-125 brachytherapy as monotherapy for early prostate cancer.

H Musunuru; M Mason; L Murray; B Al-Qaisieh; P Bownes; J Smith; K Franks; B Carey; D Bottomley; A M Henry

首页> 外文期刊>Clinical oncology >Second primary cancers occurring after I-125 brachytherapy as monotherapy for early prostate cancer.

【24h】

Second primary cancers occurring after I-125 brachytherapy as monotherapy for early prostate cancer.

机译：I-125近距离放射治疗后发生的第二种原发性癌症是早期前列腺癌的单一疗法。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Overall, the incidence of SPC after I-125 is comparable with other published data with no significant excess more than 5 years from treatment. Mortality secondary to SPC of the bladder or rectum is unusual.

机译：总体而言，I-125后SPC的发生率可与其他已发表的数据相媲美，治疗后5年以上无明显过剩。继发于膀胱或直肠SPC的死亡率异常。

著录项

来源
《Clinical oncology》 |2014年第4期|共6页
作者
H Musunuru; M Mason; L Murray; B Al-Qaisieh; P Bownes; J Smith; K Franks; B Carey; D Bottomley; A M Henry;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
入库时间 2022-08-18 09:34:22

相似文献

外文文献
中文文献
专利

1. Second primary cancers occurring after I-125 brachytherapy as monotherapy for early prostate cancer. [J] . H Musunuru, M Mason, L Murray, Clinical oncology . 2014,第4期

机译：I-125近距离放射治疗后发生的第二种原发性癌症是早期前列腺癌的单一疗法。
2. Permanent prostate brachytherapy monotherapy with I-125 for low- and intermediate-risk prostate cancer: Outcomes in 974 patients [J] . Routman David M., Funk Ryan K., Stish Bradley J., Brachytherapy . 2019,第1期

机译：具有I-125的永久前列腺近距离放射治疗单疗法，用于低和中间风险前列腺癌：974名患者的结果
3. Long-Term Efficacy and Toxicity of Low-Dose-Rate I-125 Prostate Brachytherapy as Monotherapy in Low-, Intermediate-, and High-Risk Prostate Cancer [J] . Kittel Jeffrey A., Reddy Chandana A., Smith Kristin L., International Journal of Radiation Oncology, Biology, Physics . 2015,第4期

机译：低剂量，中度和高危前列腺癌低剂量率I-125前列腺近距离放射疗法作为单一疗法的长期疗效和毒性
4. Modern Brachytherapy Techniques - Real-Time High Dose Rate Brachytherapy for Prostate Cancer [C] . D. Miszczak Acta physica polonica A . 2008

机译：现代近距离放射治疗技术-前列腺癌实时高剂量率近距离放射治疗
5. A comparative study of quality of life in patients with low-and intermediate-risk prostate cancer treated at a single institution: Stereotactic radiotherapy vs. high dose-rate brachytherapy monotherapy vs. high dose-rate brachytherapy boost [D] . Helou, Joelle. 2017

机译：单一机构治疗的中低危前列腺癌患者生活质量的比较研究：立体定向放疗与高剂量率近距离放射疗法单药疗法与高剂量率近距离放射疗法增强
6. Analysis of monotherapy prostate brachytherapy in patients with prostate cancer. Initial PSA and Gleason are important for recurrence? [O] . Pedro Galego, Fernando C. Silva, Luís Campos Pinheiro 2015

机译：前列腺癌患者单药前列腺近距离放射治疗的分析。最初的PSA和Gleason对复发是否重要？
7. Permanent Prostate Brachytherapy Monotherapy With I-125 for Low- and Intermediate-Risk Prostate Cancer: Outcome in 966 Patients [O] . R.K. Funk, B.J. Davis, L.A. Mynderse, 2015

机译：具有I-125的永久性前列腺近距离放射治疗单疗法，用于低和中等风险前列腺癌：966名患者的结果

Second primary cancers occurring after I-125 brachytherapy as monotherapy for early prostate cancer.

摘要

著录项

相似文献

相关主题

期刊订阅